Leave Your Message
ADT1103-Brazikumab Biosimilar-(IL23A)-Research Biosimilar Antibody
Antibody

ADT1103-Brazikumab Biosimilar-(IL23A)-Research Biosimilar Antibody

  • Catalog Number ADT1103
  • Host CHO Cells
  • Species Human
  • Target IL23A
  • Application ELISA, IHC, FC, IP, IF, Inhibition, PK

Our services include everything from early-stage development to full-scale production, providing a comprehensive solution that meets your needs without breaking your budget.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

IL23A is a gene encoding the p19 subunit of interleukin-23 (IL-23), a pro-inflammatory cytokine critical in immune responses. IL-23 is a heterodimer composed of IL23A (p19) and IL12B (p40), the latter shared with IL-12. This cytokine is pivotal in driving T helper 17 (Th17) cell responses, linking it to autoimmune diseases and chronic inflammation.

Product Specification

Catalog Number

ADT1103

Product Name

ADT1103-Brazikumab Biosimilar-(IL23A)-Research Biosimilar Antibody

Clonity

Monoclonal

Alternate Names

anti-IL13a antibody,  anti IL13a antibody,  recombinant IL13a,  IL13a antibody,  anti-IL13a monoclonal antibody,  IL13a antibodies,  IL13a recombinant antibody,  IL13a blocking antibody

Alias

AMG-139,  MEDI2070

Host

CHO Cells

Species

Human

Target

IL23A

Gene ID

51561

Isotype

IgG2 Lambda

Size

1mg, 5mg

Research Area

Immunology

CAS Number

1610353-18-8

Product Description

Brazikumab (INN,  development code MEDI2070) is a human monoclonal antibody designed for the treatment of Crohn's disease. This drug was developed by MedImmune.

Application

ELISA,  IHC,  FC,  IP,  IF,  Inhibition,  PK

Purity

>95% as determined by SDS-PAGE

Concentration

batch dependent

Buffer

Supplied in PBS,  PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

Reference

1. Oppmann,  B.,  Lesley,  R.,  Blom,  B.,  et al. (2000). “Novel p19 protein engages IL-12p40 to form a cytokine that induces autoimmune inflammation.” The Journal of Experimental Medicine,  192(7),  821-828.
2. Parham,  C.,  et al. (2010). “IL-23 and IL-17 in the pathogenesis of autoimmune disease.” Nature Reviews Immunology,  10(1),  1-12.
3. Langrish,  C. L.,  et al. (2005). “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.” The Journal of Experimental Medicine,  201(2),  233-240.